Noveko International IncTSX: EKO

/C O R R E C T I O N from source -- Noveko International Inc./

· Issued by Noveko International Inc via CNW

In c2962 sent today at 09:22e, an error occurred in the first paragraph.

"(...) the Influenza A Virus (H1N1) responsible for the human swine flu"

should have read "the Influenza A Virus (H1N1) similar to the one

responsible for the human swine flu". Corrected copy follows:

Effectiveness of the Noveko(TM) Antimicrobial Face Mask against the Human

Influenza A Virus (H1N1)

Symbol: EKO / TSX

MONTREAL, May 12 /CNW Telbec/ - Noveko International Inc. ("the Company") announces that it has received preliminary results of tests conducted by Microbiotest Lab, an independent laboratory located in Sterling, Virginia, USA, on the Noveko(TM) antimicrobial masks with respect to the Influenza A Virus (H1N1) similar to the one responsible for the human swine flu. The purpose of these tests was to evaluate the effectiveness of Noveko(TM) face mask materials to inactivate this virus on direct contact and to simulate the use of the face mask by a user. The preliminary results have demonstrated a bio-efficacy of a Log 3 Reduction over a period of 30 minutes.

"These preliminary results are very encouraging since they show the effectiveness of our masks to inactivate the Human Influenza A Virus (H1N1) at 99.9% over a period of 30 minutes. Even if the spread of the human swine flu currently appears to be in a declining phase, many scientists fear a more severe outbreak in fall. We thus anticipate that our sales of face masks and of our AZURO(TM) antiseptic disinfectants should increase in the next few months", stated Mr. Alain Bolduc, President and Chief Operating Officer of the Company.

Profile

Noveko International Inc. offers innovative solutions worldwide in the biomedical and environmental fields. The Company, through its subsidiaries, specializes in the following business segments: the development and marketing of products derived from its patented antimicrobial filtration technology, primarily air filters, surgical masks and respirators, as well as other antimicrobial products such as AZURO(TM) disinfectants and - the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. The Company undertakes no obligation to update or revise the forward-looking statements to account for new events or new circumstances, except where provided for by applicable legislation.

Noveko International Inc on 6ix

Earlier from Noveko International

Later from Noveko International

All Noveko International news releases